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Abstract
Background: The annual incidence and temporal trend of severe malaria and community-acquired bacteraemia
during a four-year period in Muheza, Tanzania was assessed.
Methods: Data on severely ill febrile children aged 2 months to 14 years from three prospective studies
conducted at Muheza District Hospital from 2006 to 2010 was pooled and analysed. On admission, each enrolled
child had a thin and thick blood film and at least one rapid diagnostic test for falciparum malaria, as well as a
blood culture. The annual incidence of bacteraemia and severe malaria among children coming from Muheza was
calculated and their temporal trend was assessed.
Results: Overall, 1, 898 severe falciparum malaria and 684 bacteraemia cases were included. Of these, 1, 356 (71%)
and 482 (71%), respectively, were from the referral population of Muheza. The incidence of falciparum malaria and
all-cause bacteraemia in Muheza decreased five-fold and three-fold, respectively, from the first to the fourth year of
surveillance (p < 0.0001). During this period, the median ages of children from Muheza admitted with severe
malaria increased from 1.7 to 2.5 years (p < 0.0001). The reduction in all-cause bacteraemia was mainly driven by
the 11-fold decline in the incidence of non-typhoidal salmonellosis. The annual incidences of Haemophilus
influenzae and pneumococcal invasive bacterial infections decreased as well but were much fewer in number.
Conclusions: These results add to the growing evidence of the decline in malaria associated with a decrease in
non-typhoidal salmonellosis and possibly other bacteraemias. Malarial prevention and control strategies may
provide a greater benefit than the mere reduction of malaria alone.
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Background
Community-acquired bacteraemia causes significant mor-
bidity and mortality among children in sub-Saharan Africa.
A recent comprehensive review that included 43, 130 chil-
dren admitted to African hospitals with a blood culture,
found that 3, 527 (8%) had a bloodstream infection [1].
Epidemiological observations suggest that strategies that
control malaria also decrease the rates of bacterial infec-
tions. Firstly, a study in The Gambia showed that the use
of insecticide-treated bed nets reduced overall child mor-
tality to an extent greater than could be attributed to
malaria alone [2]. Secondly, a trial of the RTS, S/AS01E
malaria vaccine in Tanzanian and Kenyan children showed
not only reduced rates of malaria in the intervention com-
pared to the control group, but decreased incidence of
pneumonia and gastroenteritis as well [3,4]. Thirdly, a
four-year intensive malaria control programme on Bioko
Island, Equatorial Guinea was associated with a decline in
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all-cause child mortality [5]. Fourthly, deployment of anti-
malaria interventions in Zanzibar was associated with a
substantial decrease in crude childhood mortality between
2002 and 2005 [6]. That malaria increases the risk of bac-
teraemia has been especially observed for invasive non-
typhoidal Salmonella (NTS) infections. NTS, mainly
Salmonella typhimurium and Salmonella enteritidis, are a
leading cause of bacteraemia in African children [7-19]. In
contrast to industrialized countries where NTS is usually
associated with a self-limited gastroenteritis [20], invasive
disease frequently occurs in sub-Saharan Africa with case
fatality rates of 4 to 27% among hospitalized children
[12,15,17,21].
The common occurrence of NTS septicaemia during
malaria outbreaks was first reported in British Guiana in
the 1920s [22]. Duggan and Beyer [23] suggested an asso-
ciation between invasive salmonellosis and malaria in
Nigerian children. In 1987, Mabey et al [7] found that
young Gambian children with NTS invasive infection
were more anaemic and more likely to have evidence of
recent malaria than were children of the same age with
other forms of septicaemia. In 1999, Berkley et al [24]
proposed that an acute episode of malaria predisposes to
bacteraemia and that the latter contributes to the clinical
picture of severe malaria. In Malawi, studies showed an
association between NTS bacteraemia and severe anae-
mia [13,18,21]. In Kenya, Brent et al [17] found that
three quarters of NTS patients with anaemia had evi-
dence of either current or recent malaria.
During the last decade, the intensity of malaria transmis-
sion has decreased in parts of sub-Saharan Africa [25-28].
In The Gambia, Mackenzie et al reported lower rates of
invasive NTS infection in children associated with reduc-
tions in malaria [29]. Most recently, researchers in Kenya
showed that the sickle cell trait decreases the risk for inva-
sive bacterial disease due to its known protection against
malaria [30]. Using data from fever surveillance studies in
children admitted to a rural district hospital in north-east-
ern Tanzania from 1 June 2006 to 31 May 2010, the
annual incidence and temporal trend of malaria and com-
munity-acquired bacteraemia was assessed.
Methods
The study site consisted of two paediatric in-patient wards
of the Teule District Hospital in Muheza, north-eastern
Tanzania. Each of the wards has 35 beds and together
receives 6, 000 child admissions per year. Teule’s referral
base is the Muheza district (including Mkinga, which was
split-off from Muheza in 2007) but the hospital accepts
patients from all over the Tanga region. Tanga, one of 26
regions of Tanzania, has an area of 26, 808 square kilo-
metres and is divided into the following districts: Lushoto,
Korogwe, Muheza (and Mkinga), Tanga, Pangani,
Handeni, and Kilindi (Figure 1). First-level medical care is
provided by primary health centres and each district
(except the newly formed Mkinga district) has a hospital.
The Bombo referral hospital is located in the coastal town
of Tanga (40 kilometres east of Muheza). Tanga region is
endemic for P. falciparum malaria. In 2007, 7% of antena-
tal clinic attendees [31] and 4% of hospitalized febrile chil-
dren [32] were HIV positive. The Tanzanian Expanded
Programme of Immunization includes the following:
Bacille Calmette-Guérin, live oral polio, diphtheria-whole
cell pertussis-tetanus-hepatitis B and monovalent measles
vaccines for children, as well as supplemental tetanus tox-
oid vaccine for women of child-bearing age. In Tanzania,
immunization against Haemophilus influenzae type b
(Hib) had just started in March 2009 and there are plans
to introduce pneumococcal vaccine [33].
Malaria diagnostic data and blood culture results from
prospective studies of febrile children undertaken at the
Teule paediatric wards from 2006 to 2010 were pooled
and analysed [32,34,35]. The first study was conducted
from June 2006 to May 2007 and enrolled children aged
two months to < 15 years with a history of fever within
the previous two days admitted during study hours [32].
Shortly thereafter, a drug trial for the treatment of severe
falciparum malaria was implemented [34]. In the trial,
malaria testing and blood culture were performed on feb-
rile children of the same age group admitted with clinical
signs of severe malaria, including coma (Blantyre coma
score ≤ 2 for children less than two years or a Glasgow
coma score ≤10 for older children), prostration (inability
to sit unsupported for children over nine months or to
drink/breastfeed), convulsions, shock (temperature gradi-
ent in the lower extremities and delayed capillary refill of
> 3 seconds or systolic blood pressure < 70 mm Hg),
respiratory distress (manifested as nasal alar flaring, costal
indrawing/recession, use of accessory muscles), desatura-
tion (oxygen saturation less than 90%), suspected severe
acidosis (deep breathing), hypoglycaemia (blood glucose
level of < 3.0 mmol/litre), severe anaemia (haemoglobin <
5 g/dl) with respiratory distress, and severe jaundice.
Finally, a second fever surveillance study was implemented
from March 2008 to May 2010 to primarily assess the bur-
den of typhoid fever [35]. The study included febrile chil-
dren of the same age group admitted during study hours
using the same criteria of clinical severity with the addition
of neck stiffness or bulging fontanel and fever of three or
more days. In all three studies, children with an obvious
non-infectious cause for admission such as trauma, sur-
gery or known malignancy were excluded. Prior to the
start and during the course of the studies, emergency
triage and management were implemented [36]. Treat-
ment and referral were provided according to Tanzanian
national guidelines.
The point-of-care and laboratory investigations con-
ducted are described in detail elsewhere [32,34,35]. Each
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child had at least one rapid diagnostic test (RDT)
for P. falciparum malaria using a PfHRP-2 based
(Paracheck™, Orchid Biomedical, Mumbai, India or
Parahit™, Span Diagnostics, Surat, India) and/or pLDH
based (OptiMAL-IT, DiaMed AG, Cressier, Switzerland)
kits. From each child, thin and thick blood films were
prepared, Giemsa-stained and read by experienced
laboratory technicians. At least 100 high-power micro-
scopic fields of the thin film were examined to exclude
the diagnosis of malaria. One to 10 ml of blood (depend-
ing on body weight) were collected from each child and
inoculated into a BactALERT™ Paediatric-fan bottle
(bioMérieux, Marcy l’Etoile, France) and incubated in the
BacT/ALERT 3D automated microbial detection system.
Blood cultures were processed according to standard
methods. The laboratory participated in a bacteriology
external quality assurance programme organized by the
Network for Surveillance of Pneumococcal Disease in the
East African Region http://www.netspear.org and identi-
fied unknown samples provided by a nearby laboratory as
part of the College of American Pathologists external
quality assurance programme. Bacterial identifications
were independently confirmed for Streptococcus pneumo-
niae and Haemophilus influenzae isolates by the KEMRI/
Welllcome Trust Centre for Geographic Medicine, Kilifi,
Kenya and for some of the Salmonellae isolates by the
Figure 1 Location of Tanga region in Tanzania, East Africa (Modified from: Wikipedia, http://en.wikipedia.org/wiki/Tanga_Region,
accessed 15 August 2011).
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Queensland Health Forensic and Scientific Services, Bris-
bane, Australia.
Each study used its standard case record form that
documented demographic details including age and resi-
dence, clinical information, as well as point-of-care and
laboratory results. Data analysis was performed using
Stata software (version 11.0). Fever was defined as history
of a rise in body temperature as recalled by a care-giver
or presence of axillary temperature ≥37.5°C on presenta-
tion. Bacteraemia was defined as fever with isolation of
pathogenic bacteria from blood culture. One blood cul-
ture was performed on admission. For the purpose of this
analysis, severe falciparum malaria was defined as fever
with a positive RDT or presence of asexual malaria para-
sites on the blood film and at least one clinical sign of
severe malaria as described above. A severe febrile illness
was defined as fever with at least one severity sign as
described above with the addition of neck stiffness, bul-
ging fontanel and fever of three or more days.
To apply consistent criteria for inclusion across the
studies, we excluded children without signs of severe
illness in the first study from the analysis (Figure 2). To
ensure a valid denominator for incidence estimates, chil-
dren with falciparum malaria and bacteraemia were clas-
sified by district. The annual incidence of bacteraemia
and severe malaria among children coming from the
referral population (Muheza, including Mkinga) was cal-
culated per 100, 000 children under 15 years of age. The
number of cases residing in the referral population was
used as the numerator and the population under 15 years
of age for each year, projected from the 2002 census [37],
as the denominator. The referral population figures used
as the denominator were 121, 465, 122, 847, 124, 322,
125, 819 children for 2006, 2007, 2008, and 2009, respec-
tively. The chi-square test for trend in counts was used
to evaluate the temporal trend of the incidence of malaria
and bacteraemia [38]. The median ages of children with
severe falciparum malaria at one-year intervals was
assessed for temporal trend using the Jonckheere-Terp-
stra test, a non-parametric test using the R function (The
R Foundation for Statistical Computing, version 2.13.0,
Vienna, Austria) [39].
Figure 2 Assembly of data.
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The three studies (from which the pooled data was
obtained) were conducted according to the principles
expressed in the Declaration of Helsinki. Written informed
consent was obtained from the parent or guardian of each
eligible child prior to his/her participation. The three stu-
dies were approved by the Tanzania Medical Research
Coordinating Committee. In addition, the first febrile ill-
ness study was approved by the London School of Hygiene
and Tropical Medicine (UK), the severe malaria drug trial
was approved by the Oxford Tropical Research Ethics
Committee (UK) and the surveillance study to assess the
burden of typhoid fever was approved by the International
Vaccine Institute - Institutional Review Board (Republic of
Korea).
Results
During the study period from June 2006 to May 2010, a
total of 6, 836 severely ill febrile children between 2
months and < 15 years old who participated in the study
were included in the analysis: 3, 091, 778 and 2, 967 from
the first, second and third studies, respectively (Figure 2).
5, 281 (77%) of 6, 836 were from the referral population of
Muheza (including Mkinga) and their characteristics, by
study group, are shown in Table 1. Bacteria were isolated
from the blood of 1, 248/6, 836 (18%), of which 564 (8%)
were considered as likely contaminants. Each of the 684
(10%) children with bacteraemia had only a single organ-
ism isolated from their blood culture. Of the 6, 836 chil-
dren, 1, 898 (28%) had severe falciparum malaria. Both
bacteraemia and severe malaria were present in 167 (2%).
Of the 6, 836 children included in the analysis, 4, 023
(59%) were > 2 months to 2 years, 2, 125 (31%) were > 2
years to 5 years and 688 (10%) were > 5 years of age. We
ranked the pathogenic bacterial isolates according to fre-
quency, by age group (Table 2). Overall and among chil-
dren less than five years of age, NTS was the principal
organism, comprising 34% of the invasive pathogens.
Other commonly isolated bacterial pathogens were Hib,
S. pneumoniae, and Escherichia coli. Salmonella typhi was
the most common isolate among those over 5 to 14 years
of age.
The children with falciparum malaria and bacteraemia
were classified by district (Table 3). Of the overall 1,
898 severe falciparum malaria and 684 bacteraemia
cases, 1, 356 (71%) and 482 (71%), respectively, were
from the referral population of Muheza (including
Mkinga). The incidence of falciparum malaria and
bacteraemia per 100, 000 children under 15 years of age
in Muheza was plotted for each year of surveillance
(Figure 3). The incidence of severe falciparum malaria
and all-cause bacteraemia decreased five-fold and three-
fold, respectively, from the first to the fourth year of
surveillance (p < 0.0001). The median age of the chil-
dren from Muheza admitted with severe malaria during
each year of surveillance was compared (Table 4). Over
the four-year period, the median age increased from 1.7
to 2.5 years (p < 0.0001). As shown in Figure 3, the
reduction in all-cause bacteraemia was mainly driven by
the 11-fold decline in the incidence of non-typhoidal
salmonellosis from 82 to 7 cases/100, 000 children/year
from the first year to the fourth year of surveillance (p <
0.0001). The annual incidences of Hib and pneumococ-
cal invasive bacterial infections had statistically signifi-
cant declines (from 21 to 4 cases/100, 000 children/year
for Hib and 34 to 7 cases/100, 000 children/year for
pneumococcal infections, p < 0.001). The incidence of
E. coli bacteraemia did not change (p = 0.56) whereas
that of typhoid fever increased from 7 cases/100, 000
children/year during the first year to 15 during the
fourth year of surveillance (p = 0.002).
As an indicator of hospital utilization the annual number
of deliveries from 2002 to 2010 was assessed (Figure 4).
There were 2, 665 deliveries in 2002, which increased to
over 3, 000 annual deliveries during 2004 to 2010.
Discussion
There was an impressive decline in the incidence of
malaria in the study site, which is consistent with previous
reports from other locations [25-30]. From the first to the
last year of surveillance, we noted an increase in the med-
ian age of children who were admitted with severe malaria,
which supports the temporal reduction of malaria trans-
mission in the area. A decrease in transmission intensity is
known to be associated with an increase in the age of
severe malaria cases [40,41]. A cluster-randomized survey
conducted in Muheza in 2008 showed that the use of an
Table 1 Characteristics of the children in the three study groups
1st study 2nd study 3rd study Total
Inclusive dates of enrolment June 2006 to May
2007
June 2007 to February
2008
March 2008 to May
2010
June 2006 to May
2010
Time period 12 months 9 months 27 months 4 years
No of children with at least one sign of severe
illness
3, 091 778 2, 967 6, 836
No (%) from Muheza 2, 447 (79) 448 (58) 2, 386 (80) 5, 281 (77)
- Mean (Standard deviation) age 2.2 (2.1) 2.3 (2.2) 2.7 (2.6) 2.4 (2.3)
- No (%) female 1, 157 (47) 217 (48) 1, 048 (44) 2, 422 (46)
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insecticide-treated or any bed net among children less
than five years of age was 54% and 71% respectively [42]
but use of indoor residual spraying is not common in the
community.
The decline of malaria in Muheza occurred in parallel
with a reduction in invasive bacterial infections, particu-
larly in non-typhoidal salmonellosis. Although over a
shorter time period, our findings are similar to those
from The Gambia, where the estimated incidence of
NTS infection in Fajara fell from 60 (1979-1984) to 10
(2003-05) cases per 100, 000 person-years. In Basse, also
The Gambia, the estimated incidence of NTS infection
fell from 105 (1989-1991) to 29 (2008) cases per 100,
000 person-years [29]. In Kenya, from 1999 to 2002,
there was a decrease in the number of paediatric admis-
sions for malaria and for not only non-typhoidal salmo-
nellosis, but other gram-negative bacteraemias [30]. In
that study, the known protective effect of the sickle cell
trait against malaria was used to evaluate whether the
association between malaria and bacteraemia was cau-
sally related. Yearly case-control studies showed that the
protective effect of sickle cell trait against bacteraemia
waned as malaria rates declined confirming that malaria
predisposes to bacteraemia. But the association between
malaria and pneumococcal bacteraemia could not be
assessed using the same method because sickle cell trait
slightly increases the risk of pneumococcal disease (even
without malaria). Thus, there is a strong suggestion that
malaria increases the risk for some bacteraemias. More
work needs to be done to understand this association.
That malaria increases the risk for bacteraemia is plausi-
ble for several reasons. The hemodynamic or inflamma-
tory processes that occur during severe malaria can
predispose to invasive bacterial infection. For example,
malarial haemolysis may lead to impaired macrophage and
neutrophil function, saturation of iron-binding proteins,
and increased iron availability to NTS, a siderophilic
organism [19]. Alternatively or in conjunction, sequestra-
tion of parasitized erythrocytes in post-capillary venules
may affect the integrity of the bowel epithelium allowing
transmigration of gram-negative bacteria. The authors are
unable to explain why bloodstream infections with E. coli,
a gram-negative organism ubiquitous in the bowel, did not
decrease. The incidence of Hib and pneumococcal bacter-
aemia in the study site decreased over the relatively short
period of four years. It is unlikely that these reductions
were due to immunization, as neither Hib nor pneumo-
coccal vaccines were widely available during the study per-
iod. Hospital-based surveillance data from Malawi showed
a decline in the number of invasive pneumococcal infec-
tions from 2000 to 2009, which paralleled the scale-up of
national antiretroviral therapy [43]. These trends are in
contrast to The Gambia where the measured incidence of
pneumococcal bacteraemia in Fajara and Basse did not
fall. Over the four-year period, the number of typhoid
fever cases in Muheza did not decrease. It is possible that
there was an on-going typhoid fever outbreak during the
third and fourth years of surveillance. However, in this
population, the association of malaria with bacteraemia is
probably most relevant in young children (among whom
malaria occurs most frequently), whereas typhoid fever
tends to occur more in the older age groups (Table 2).
There are several limitations of our study. First, the ana-
lysis used pooled data from three studies with slightly dif-
ferent enrolment criteria. To ensure consistent inclusion
criteria in our analysis, the non-severely ill children in the
first study were excluded from the analysis. The period
from June 2007 to February 2008 had the highest percen-
tage of children with severe malaria (55%) as the enrol-
ment criteria during the drug trial was focused on signs of
Table 2 Number (%) of bacterial isolates ranked* according to frequency by age group, 1 June 2006 to 31 May 2010
No (%) among
> 2 m to 2 y
(n = 4, 023)
Rank No (%) among
> 2 y to 5 y
(n = 2, 125)
Rank No (%) among
> 5 y to < 15 y
(n = 688)
Rank Total no (%)
(n = 6, 836)
Overall rank
Gram-positive
- Streptococcus pneumoniae 55 (13) 4 20 (12) 3 10 (13) 2 85 (12) 3
- beta haemolytic Streptococci, Group A & C 18 (4) 5 5 (3) 7 2 (3) 6 25 (4) 7
- Staphylococcus aureus 16 (4) 6 7 (4) 6 9 (11) 3 32 (5) 6
Gram-negative
- Salmonella typhi 5 (1) 7 21 (13) 2 33 (42) 1 59 (9) 5
- Nontyphoidal salmonella species 168 (38) 1 58 (35) 1 6 (8) 5 232 (34) 1
- Haemophilus influenzae (type B) 69 (16) 2 16 (10) 4 7 (9) 4 92 (14) 2
- Escherichia coli 68 (16) 3 9 (6) 5 2 (3) 6 79 (12) 4
- Acinetobacter species 4 (1) 8 5 (3) 7 0 (0) 8 9 (1.3) 8
Other 5 (1) 21 (13) 33 (42) 59 (8.6)
All pathogenic bacteria 440 (11) 165 (8) 79 (11) 684 (10)
Contaminants 382 (9) 140 (7) 42 (6) 564 (8)
* Rank (by age group and overall) was the same for organisms with the same frequency.
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Table 3 Number (%) of children with bacteraemia and severe falciparum malaria by residence, 1 June 2006 to 31 May 2010
District (population under 15 years*) Number (%) with severe falciparum malaria Number (%) with bacteraemia
All pathogenic NTS Hib S. pneumoniae E. coli S. typhi S. aureus
Referral population:
Muheza** (124, 322) 1, 356 (71.4) 482 (70.5) 147 (63.4) 56 (60.9) 69 (81.2) 56 (70.9) 49 (83.1) 22 (68.8)
Non-referral population:
Lushoto (218, 957) 1 (0.1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Korogwe (118, 460) 61 (3.2) 18 (2.6) 9 (3.9) 0 (0) 4 (4.7) 2 (2.5) 0 (0) 2 (6.3)
Tanga (98, 177) 10 (0.5) 6 (0.9) 2 (0.9) 1 (1.1) 0 (0) 0 (0) 2 (3.4) 0 (0)
Pangani (18, 292) 10 (0.5) 3 (0.4) 1 (0.4) 1 (1.1) 0 (0) 0 (0) 0 (0) 1 (3.1)
Handeni (123, 762) 374 (19.7) 151 (22.1) 63 (27.2) 27 (29.3) 8 (9.4) 21 (26.6) 7 (11.9) 6 (18.8)
Kilindi (74, 228) 1 (0.1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
District not recorded 85 (4.5) 24 (3.5) 10 (4.3) 7 (7.6) 4 (4.7) 0 (0) 1 (1.7) 1 (3.1)
Total Tanga region (776, 198) 1, 898 (100) 684 (100) 232 (100) 92 (100) 85 (100) 79 (100) 59 (100) 32 (100)
*2008 population projected from the 2002 Tanzania Population and Housing Census (Tanzania National Bureau of Statistics 2006).
**Includes Mkinga which was split-off from Muheza in 2007.
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severe malaria and did not include neck stiffness, bulging
fontanel and fever of three or more days. This more strin-
gent enrolment criteria likely resulted in the failure to
detect some clinically important bacteraemia cases, parti-
cularly typhoid fever, as reflected in the lowest incidence
during the second year. But the overall trend showed a
decrease in bacteraemias from the beginning to the end of
surveillance. Second, the analytic plan was not developed
a priori. Prospective studies on community-acquired
bloodstream infections in sub-Saharan Africa are scarce
[1] and the authors took advantage of this four-year sur-
veillance dataset to explore potential associations. Third, it
is possible that not all cases in the community were cap-
tured since detection was done using a passive hospital-
based surveillance method. Actual disease burden may be
higher. Fourth, with the exception of malaria and NTS,
the numbers of bacteraemia cases used to calculate inci-
dence were few and the duration of surveillance was lim-
ited to four years. Changes in incidence may be due to
natural fluctuations in disease occurrence. Fifth, in this
descriptive study, a causal relationship between the decline
in malaria with that of NTS and possibly other invasive
bacterial infections cannot be assessed. HIV infection,
which is known to be associated with invasive NTS disease
[19], as well as other bacterial infections, was not included
in the analysis. The authors are not aware of any data sug-
gesting changes in HIV/AIDS prevalence in the area dur-
ing the study period. Sixth, it could be argued that other
factors may have caused the decrease in bacteraemia inci-
dence such as changes in health utilization behaviour.
Alternative treatment options for fevers could have
become available in the area during the study period. To
the authors’ knowledge, there were no such alterations in
treatment options; changes in referral patterns of severe
febrile illness are particularly unlikely. Although Mkinga
district was formed, there has been no hospital established
there and its health centres have approximately the same
level of facilities and staffing as they did in 2005. The
increasing number of deliveries at Teule indicates sus-
tained hospital usage. Finally, it is possible that
Figure 3 Annual incidence (per 100, 000 children under 15 years of age) of severe falciparum malaria and bacteremia in Muheza*.
Table 4 Median age in years of children from Muheza
admitted with severe falciparum malaria during each
year of surveillance
Time period (number of children) Median age in years
N = 1, 356
1 June 2006 - 31 May 2007 (N = 664) 1.7
1 June 2007 - 31 May 2008 (N = 379) 2.0
1 June 2008 - 31 May 2009 (N = 180) 2.4
1 June 2009 - 31 May 2010 (N = 133) 2.5
Test for temporal trend < 0.0001
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improvements in socio-economic status and living stan-
dards of the referral population caused the reduction in
cases but such data is not available. It seems likely that
there was a real decrease in malaria and bacteraemia rates
during the study period.
These findings provide additional evidence for the asso-
ciation of malaria with bacterial disease. Strategies that
prevent malaria also inhibit the risk of non-typhoidal sal-
monellosis and other bacteraemias. This has important
implications for the impact of malaria control on all-cause
child mortality. In Bioko there was a large drop in under-
five mortality from 152 to 55/1000 births following malaria
control [5]. In Zanzibar, the decline in falciparum malaria
prevalence following the deployment of artemisinin-based
combination therapy and distribution of long-lasting
insecticidal nets was associated with a decrease in infant,
child (aged 1-4 years) and under-five crude mortality by
33%, 71%, and 52%, respectively [6].
Conclusion
From 2006 to 2010, a decline in malaria infections in
Muheza was associated with a reduction in invasive NTS
disease and other bacteraemias. Continued surveillance in
Muheza would be important to understand longer-term
trends.
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